Takeda reports positive Phase 3 psoriasis results for zasocitinib versus deucravacitinib

Oxurion in talks to acquire Eclevar's MedTech CRO business and assets

DBV Technologies submits FDA application for VIASKIN Peanut Patch in children

Vanda Pharmaceuticals reports positive Phase III results for HETLIOZ in Delayed Sleep-Wake Phase Disorder

AstraZeneca invests USD2bn in Summit Therapeutics to advance ADC and cancer-drug combinations

Lakewood-Amedex Biotherapeutics reports positive data for clinical candidate Nu-3 in diabetic foot ulcers

BRC Therapeutics participates in regulators' workshop advancing botanical drug development

Viking Therapeutics closes offerings of common stock and convertible senior notes

Ascletis reports positive results from ASC50 clinical study for treatment of plaque psoriasis

4basebio announces Phase I cell therapy programme partnership with TriLink

Kodiak Sciences to present topline Phase 3 study results for Zenkuda and KSI-501 in wet AMD

IASO Bio presents first-in-human data of BCMA-targeted in vivo CAR-T cell therapy IASO206 at 2026 IMS

Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer

Lundbeck to relocate US headquarters to Greater Boston